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introduction: Although heart failure (HF) is characterized by elevation in left ventricular end-diastolic pressure (LVEDP), none of the existing 
epidemiologic criteria for HF diagnosis is validated against invasive hemodynamic measurements.
methods: We recruited 197 patients undergoing diagnostic cardiac catheterization. We performed physical exam and identified elements from the 
medical records to define ten HF diagnostic criteria (Table). We compared sensitivity (Sn), specificity (Sp), agreement (kappa) and receiver operating 
characteristic (ROC) area for the different criteria using different thresholds for abnormal LVEDP (≥12 and ≥15 mmHg).
results: The mean age was 63±12 years and 57% were men. Using LVEDP≥15 mmHg as the gold standard, the most sensitive criteria was MBC (Sn 
85%, 95%CI 71%-94%) and the least sensitive was GTH (Sn 58%, 95%CI 49%-67%). FHS was the most specific criteria (Sp 77%, 95%CI 67%-84%) 
and ESC was the least specific (Sp 65%, 95% CI 56%-74%). Results were similar using a threshold for abnormal LVEDP ≥ 12 mmHg. The highest ROC 
was obtained using FHS criteria for both LVEDP ≥ 12 and ≥15 mmHg (Table).
conclusions: Existing criteria for diagnosing HF demonstrate moderate diagnostic utility compared to invasive hemodynamic measurements. 
Future epidemiologic studies should consider optimizing the HF diagnostic algorithm by combining several clinical and administrative data.
Table. Test characteristics for different heart failure diagnostic criteria against abnormal LVEDP 
LVEDP ≥ 12 mmHg LVEDP ≥ 15 mmHg
Sn (%) Sp (%) ROC area [95% CI] Sn (%) Sp (%) ROC area [95% CI]
ARIC 80 53 0.67 [0.60 - 0.73] 72 71 0.71 [0.65 - 0.78]
MBC 96 52 0.74 [0.69 - 0.79] 85 68 0.76 [0.70 - 0.83]
CHS 88 51 0.69 [0.63 - 0.75] 78 66 0.72 [0.65 - 0.79]
ESC 75 52 0.63 [0.57 - 0.70] 60 65 0.62 [0.55 - 0.69]
FHS 83 62 0.73 [0.67 - 0.79] 70 77 0.73 [0.67 - 0.80]
GTH 70 58 0.64 [0.57 - 0.71] 59 76 0.67 [0.61 - 0.74]
ICD-9 87 51 0.69 [0.63 - 0.75] 77 67 0.72 [0.66 - 0.79]
NHANES 89 53 0.71 [0.65 - 0.76] 82 69 0.76 [0.69 - 0.82]
SELF 87 52 0.70 [0.64 - 0.76] 74 67 0.71 [0.64 - 0.78]
WHI 77 61 0.69 [0.62 - 0.75] 62 75 0.68 [0.62 - 0.75]
ARIC = Atherosclerosis Risk in Communities, MBC = Modified Boston Criteria, CHS = Cardiovascular Health Study, ESC = European Society of 
Cardiology, FHS = Framingham Heart Study, GTH = Gothenburg, ICD9 = International Classification of Diseases, NHANES = National Health and 
Nutrition Examination Survey, SELF= self-assessment, and WHI = Women’s Health Initiative.
